The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis

المؤلفون المشاركون

Karaarslan, Ahmet
Oksel, Fahrettin
Kobak, Şenol

المصدر

Case Reports in Rheumatology

العدد

المجلد 2013، العدد 2013 (31 ديسمبر/كانون الأول 2013)، ص ص. 1-4، 4ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2013-11-12

دولة النشر

مصر

عدد الصفحات

4

التخصصات الرئيسية

الأمراض

الملخص EN

Rheumatoid arthritis (RA) is considered as a connective tissue disease while ankylosing spondylitis (AS) is a prototype of spondyloarthritis.

These diseases are seen concomitantly only very rarely.

Also, rituximab has proven efficacy in the treatment of RA while its role in the treatment of AS is unclear.

In this presentation, the concomitant presence of RA and AS in a 43-year-old male patient as well as the efficacy and safety of rituximab is discussed.

Rituximab was given due to lack of response to treatment with anti-TNF-alpha.

Evaluations made at the 6th and 12th months of treatment showed complete response for RA and partial response for AS.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Kobak, Şenol& Karaarslan, Ahmet& Oksel, Fahrettin. 2013. The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis. Case Reports in Rheumatology،Vol. 2013, no. 2013, pp.1-4.
https://search.emarefa.net/detail/BIM-498493

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Kobak, Şenol…[et al.]. The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis. Case Reports in Rheumatology No. 2013 (2013), pp.1-4.
https://search.emarefa.net/detail/BIM-498493

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Kobak, Şenol& Karaarslan, Ahmet& Oksel, Fahrettin. The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis. Case Reports in Rheumatology. 2013. Vol. 2013, no. 2013, pp.1-4.
https://search.emarefa.net/detail/BIM-498493

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-498493